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Objective The aim of this study was to assess whether serum cytokine levels cor-
relate with clinical periodontal parameters in health or disease.
Materials and Methods Male subjects (40–60 years) with CP (n = 30), CP + CHD 
(n = 30), and healthy controls (n = 20) had plaque index (PLI), gingival index (GI), 
bleeding on probing, probing pocket depth (PPD), and clinical attachment level (CAL) 
evaluated. Serum IL-1β and IL-6 levels were quantified using enzyme-linked immuno-
sorbent assay.
Results PLI, GI, PPD, and CAL were significantly higher in patients with CP + CHD 
compared to those with CP. Serum levels of IL-1β and IL-6 were also significantly higher 
in CP + CHD compared to those with CP, with both groups also being significantly 
higher than controls. There was a strong correlation between IL-1β and PPD and CAL 
and between IL-6 and GI and CAL in the CP group and between IL-6 and GI and PPD in 
the CP + CHD group.
Conclusion The results provide further evidence that periodontitis triggers systemic 
inflammation. Cytokine levels in patients with periodontitis may represent a useful 
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Introduction
Coronary artery disease arises as an outcome of hardening 
and lumen reduction of the arteries that supply the heart 
due to atherosclerotic plaque buildup.1 It is characterized 
by local and systemic host responses, in which cells such as 
B and T lymphocytes and macrophages have an important 
role in the pathogenesis of this disease by releasing of cyto-
kines and other inflammatory mediators.2 For many years, 
the coronary heart disease (CHD) is recognized as one of the 
most common causes of mortality and morbidity.3
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Chronic periodontitis (CP) is a destructive inflammatory 
disease affecting the supporting tissues of the tooth includ-
ing the periodontal ligament and alveolar bone.4 A large body 
of work has been focused to the relationship between CHD 
and CP. These diseases not only share several common risk 
factors such as smoking, but also share potential mechanistic 
links through the presence of chronic inflammation.5
A large number of studies have indicated the presence 
of a positive correlation of clinical signs and inflammatory 
changes in CP with atherosclerosis and CHD. CP may amplify 
systemic inflammatory mediator levels as a consequence of 
persistent infection which may affect other organs and sys-
tems, including the vascular endothelium, thus potentially 
contributing to inflammation-associated atherosclerotic dis-
ease.6 In serologic studies, high titers of antibodies to peri-
odontal bacteria are found in patients with atherosclerosis 
and CHD disease, and some viable bacteria can be isolated 
from atherosclerotic plaques.7
Through their effects on inflammation and the immune 
system, interleukin-1β (IL-1β) and interleukin-6 (IL-6) are 
considered important mediators of inflammation in both 
periodontitis and atherosclerosis.8 In periodontal tissues, 
IL-1β can stimulate bone resorption,9 neutrophil and mono-
cyte migration from the vasculature into the periodontal 
tissue,10 and expression of proatherogenic members of the 
tumor necrosis factor super family.11 IL-6 may also contribute 
to the relationship between CP and CHD through stimulation 
of monocyte differentiation into osteoclasts resulting in bone 
destruction12 and exacerbation atherosclerotic plaque devel-
opment and destabilization through a variety of mechanisms 
such as the release of other proinflammatory cytokines, acti-
vation of metalloproteinases (MMPs), and increased acute 
phase protein secretion.13
The aim of this study was to investigate the relationship 
between serum levels of IL-1β and IL-6 with periodontitis 
and CHD. We have shown that clinical disease parameters 
are further raised in periodontitis patients with CHD and 
that serum IL-1β and IL-6 levels represent potential mark-
ers of this process. The presence of these interrelated dis-
eases must be taken into consideration as guidelines suggest 
patients with moderate to severe periodontitis are notified 
of the increased risk of cardiovascular disease, which may 
necessitate further evaluation.14
Materials and Methods
Eighty male subjects aged between 40 and 60 years were 
recruited to this study from the Cardiology Clinic of the 
Baghdad Teaching Hospital and Periodontics Department of 
the College of Dentistry, University of Baghdad, Baghdad, Iraq. 
This study was conducted after the approval was granted by 
the relevant scientific committee (Ref. 122 at 08/11/2015). 
All the individuals were informed about the purpose of this 
study and consented to participate in this study. The sub-
jects were divided into study and control groups. Thirty 
patients were examined and shown to possess CP and CHD 
(CP + CHD) diagnosed using the catheterization technique 
and were receiving clopidogrel medication (Plavix/75 mg). 
A further 30 patients were examined and shown to have CP 
as they had equal or less than 30% sites with pocket depths 
≥ 4 mm with clinical attachment loss of 1 to 2 mm or greater 
in accordance to the worldwide classification system for 
periodontal disease (PD).15
The control group consisted of 20 patients with no CHD 
and clinically healthy periodontium with gingival index (GI) 
scores < 0.5, no pockets, or clinical attachment loss. However, 
certain exclusion criteria were applied including the pres-
ence of any chronic systemic diseases such as diabetes mel-
litus, smoking, those using medication such as antimicrobial 
and anti-inflammatory drugs, or having any periodontal 
treatment within the last 3 months.
Clinical periodontal examination was performed using 
a Michigan O periodontal probe on four surfaces (mesial, 
buccal/labial, distal, and lingual/palatal) of all teeth except 
third molars. All subjects had at least 20 teeth. The collected 
clinical data consisted of plaque index (PLI) system,16 GI sys-
tem,17 bleeding on probing (BOP),18 probing pocket depth 
(PPD), and clinical attachment level (CAL).19
Following examination of the clinical periodontal param-
eters, 5 mL venous blood was collected from study and 
control groups. After centrifugation, serum samples were 
kept frozen at –40°C and analyzed for IL-1β and IL-6 using 
enzyme-linked immunosorbent assay (Bioassay Technology 
Laboratory, Shanghai Korain Biotech Co.).
Data were processed and analyzed for both descrip-
tive and inferential analyses using SPSS (version 23, IBM, 
United States) and Microsoft Excel (version 2010, Microsoft 
Corporation, United States). The statistical analysis for the 
determination of serum IL-1β and IL-6 was assessed using 
t-test, analysis of variance test followed by Tukey’s post hoc 
test, and Pearson’s coefficient of correlation.
Results
The results revealed that mean values of PLI, GI, PPD, and 
CAL were significantly higher in the CP + CHD group com-
pared with the CP and control groups. The percentage of 
score 1 BOP sites was significantly higher in the CP + CHD 
group than the CP group. The statistical analyses of clinical 
periodontal parameters for all groups are summarized in 
►Figs. 1 and 2 and ►Table 1.
The mean serum levels of IL-1β and IL-6 were signifi-
cantly higher in the CP + CHD group followed by the CP 
group then the control group (p < 0.001) (►Fig. 3A and B ). 
The correlation analysis shows that there was a weak posi-
tive correlation between BOP with serum IL-1β levels in the 
CP group, while there were moderately significant positive 
correlations with both PLI and GI (p < 0.05), and a significant 
positive correlation with PPD and CAL (p < 0.01). For the CP + 
CHD group, there were weak positive correlations between 
serum IL-1β levels with PLI and PPD, while highly signifi-
cant positive correlations were observed with GI, BOP, and 
CAL (p < 0.05). In the CP group there was moderate positive 
correlation between serum IL-6 levels and PLI, BOP, and PPD 
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(p < 0.05) as well as strong positive correlations with GI and 
CAL (p > 0.01). In the CP + CHD group significant positive 
correlations were revealed between serum IL-6 levels with 
GI and PPD (p < 0.01), while the correlation was weak with 
PLI and BOP and moderate with CAL (p < 0.05), as shown in 
►Table 2.
Discussion
CP is a multifactorial inflammatory disease characterized by 
irreversible progressive loss of the tooth supporting tissues. 
The progression of this disease is influenced by an imbalance 
between the microbial dental biofilm and the host immune 
Fig. 1 Percentage of bleeding on probing (BOP) in patients with chronic periodontitis (CP) and coronary heart disease patients affected by 
periodontitis (CP-CHD).
Fig. 2 Mean probing pocket depth (PPD) and clinical attachment level (CAL) in patients with chronic periodontitis (CP) and coronary heart 
disease patients affected by periodontitis (CP-CHD). ***Indicates statistically significant differences at p ≤ 0.001.
Table  1  Mean plaque (PLI) and gingival index (GI) scores are significantly higher in association with chronic periodontitis (CP) 
and coronary heart disease patients affected by periodontitis (CP-CHD) when compared with the control group (Con)
Indices Groups Mean ± SD Comparisons p-Value*
PLI Control 0.50 ± 0.112 Con vs. CP < 0.001
CP 1.69 ± 0.125 Con vs. CHD < 0.001
CP + CHD 1.78 ± 0.136 CP vs. CP + CHD < 0.05
GI Control 0.57 ± 0.119 Con vs. CP < 0.001
CP 1.74 ± 0.121 Con vs. CP + CHD < 0.001
CP + CHD 1.83 ± 0.131 CP vs. CP + CHD < 0.05
Abbreviation: CP, chronic periodontitis; CHD, coronary heart disease; PLI, plaque index; GI, Gingival index; SD, standard deviation.
*ANOVA test and post hoc.
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response including enhanced levels of cytokines such as IL-1β 
and IL-6, which can exacerbate periodontal destruction.2 The 
increase in the dental biofilm microbiota may increase the sus-
ceptibility to various systemic diseases such as cardiovascular 
disease, mainly through bacteremia and systemic inflamma-
tion. The presence of periodontal pathogens in vascular tissue 
may directly stimulate atheroma formation and maturation.19
The mean values of PLI, GI, PPD, and CAL were higher in the 
CP + CHD group than the CP group, which could be explained 
as hospitalized patients may neglect oral hygiene measures, 
thus more gingival inflammation could be seen. Plaque bio-
film bacteria secrete a variety of byproducts (toxins, enzymes, 
and H
2
S) that provoke an inflammatory response which can 
promote periodontal loss, pocket formation, bone resorption, 
mobility, and tooth loss.5,20,21
The serum levels of IL-1β and IL-6 in this study were 
higher in the study group with CP and atherosclerotic heart 
disease than other groups with highly significant differences 
(p ≤ 0.01). Similar studies are lacking in the literature, while 
some have demonstrated similar findings22 others have 
shown no baseline differences in IL-6 levels in patients with 
periodontitis and CHD.23 In a study of cardiovascular disease 
patients, IL-6 levels were higher in those with increased CAL 
but did not appear to specifically distinguish those with CP.24
The positive correlation of serum IL-1β levels with clinical 
periodontal parameters, in both study groups, suggests that 
IL-1β levels are a potentially sensitive and reliable marker of 
chronic inflammation activity and resultant tissue destruc-
tion. IL-1β is thought to be important in the pathogenesis 
of PD25 possibly due to its ability to cause atheromatous plaque 
instability through the upregulation of MMPs at the site of 
plaque formation. It also mediates vascular smooth muscle 
cell proliferation and migration during inflammation, which 
represents a key step in the development of atherosclerosis.26  
In periodontal tissues, IL-1β is known to stimulate prolifer-
ation of keratinocytes, fibroblasts, and endothelial cells and 
augments fibroblast synthesis of collagenase, hyaluronate, 
fibronectin, and prostaglandin E2. In addition, it upregulates 
Fig. 3 Mean serum concentration values of interleukin (IL)-1β (A) and IL-6 (B) in patients with chronic periodontitis (CP) and coronary heart 
disease patients affected by periodontitis (CP-CHD) compared with the control group. *p < 0.05; ***p < 0.001.
Table  2  Serum levels of IL-1β and IL-6 and clinical periodontal parameters in CP + CHD and CP group
Cytokine Groups Statistics PLI GI BOP PPD CAL
IL-1β CP Pearson’s r 0.44 0.409 0.29 0.638 0.701
p-value§ 0.01 0.02 0.01 < 0.001 < 0.001
Significance * * NS **** ****
CP + CHD Pearson’s r 0.36 0.49 0.433 0.378 0.457
p-value§ 0.05 0.005 0.01 0.039 0.011
Significance NS ** * * *
IL-6 CP Pearson’s r 0.41 0.63 0.42 0.454 0.619
p-value§ 0.02 < 0.001 0.01 0.01 < 0.001
Significance * **** * * ****
CP + CHD Pearson’s r 0.34 0.62 0.365 0.645 0.453
p-value§ 0.06 < 0.001 0.04 < 0.001 0.016
Significance NS **** * **** *
Abbreviations: BOP, bleeding on probing; CAL, clinical attachment level; CHD, coronary heart disease; CP, chronic periodontitis; GI, gingival index; IL, 
interleukin; NS, not significant; PLI, plaque index; PPD, probing pocket depth.
§Chi-square test; *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001; ****P  ≤ 0.0001. 
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MMP and downregulates tissue inhibitor of MMP production 
leading to bone resorption, an increase in PPD, and loss of 
attachment.27
Serum IL-6 may be upregulated due to systemic exposure 
to oral bacteria and lipopolysaccharide that enter the cir-
culation from periodontal pocket, which in turn stimulates 
the liver to release acute phase proteins including C-reactive 
protein.28 In atherosclerosis, IL-6 has proinflammatory and 
procoagulant effects, thus may contribute to the progression 
of atherosclerosis. Also, the retention of low-density lipopro-
tein in the intima of a vessel may undergo oxidative changes 
and consequently may increase secretion of chemokines and 
proinflammatory cytokines, such as IL-6.29
The positive correlation between IL-6 levels and differ-
ent periodontal parameters may be due to the dental plaque 
bacteria and bacterial byproducts inducing release of proin-
flammatory cytokines which in turn gives rise to increased 
systemic IL-6 levels. IL-6 is also secreted by osteoblasts which 
may have an effect on differentiation of monocyte into osteo-
clasts that have key role in alveolar bone resorption which 
is the hallmark of periodontitis progression.8 It has also 
been revealed that in clinically healthy gingiva, inflamma-
tory mediators such as IL-1β and IL-6 are present at low lev-
els30 and that nonsurgical treatment of periodontal disease 
can result in reduced IL-6 levels.23
Conclusion
Patients with both CP and CHD have higher levels of the 
inflammatory markers IL-1β and IL-6 than those with just 
periodontitis or control subjects. Cytokine levels also cor-
related with several clinical periodontal parameters. These 
results may be used to predict patients with periodontitis 
that are at increased risk of developing atherosclerotic heart 
disease, and such correlation may be used as a marker for 
disease activity. Increase awareness to obtain an optimum 
standard of periodontal health is necessary to minimize the 
resultant bacteremia, which may influence the health of sus-
ceptible organs including those of the cardiovascular system.
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